SAT1
Diamine acetyltransferase 1
Also known as: SAT, SAT1_HUMAN, SSAT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21673
- Gene
- SAT1
- Ensembl
- ENSG00000130066
- Chromosome
- X
- Canonical length
- 171 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the acetyltransferase family, and is a rate-limiting enzyme in the catabolic pathway of polyamine metabolism. It catalyzes the acetylation of spermidine and spermine, and is involved in the regulation of the intracellular concentration of polyamines and their transport out of cells. Defects in this gene are associated with keratosis follicularis spinulosa decalvans (KFSD). Alternatively spliced transcripts have been found for this gene.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
171 residues, UniProt reviewed canonical sequence.
>P21673|SAT1
1 MAKFVIRPAT AADCSDILRL IKELAKYEYM EEQVILTEKD LLEDGFGEHP FYHCLVAEVP
61 KEHWTPEGHS IVGFAMYYFT YDPWIGKLLY LEDFFVMSDY RGFGIGSEIL KNLSQVAMRC
121 RCSSMHFLVA EWNEPSINFY KRRGASDLSS EEGWRLFKID KEYLLKMATE ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 971 nTPM
Expression across tissuesHPA
Tissue
- lung: 971 nTPM
- choroid plexus: 954 nTPM
- bone marrow: 834 nTPM
- liver: 735 nTPM
- adipose tissue: 612 nTPM
- salivary gland: 576 nTPM
Single-cell type
- epididymal basal cells: 11,105 nCPM
- neutrophils: 8,490 nCPM
- kupffer cells: 6,462 nCPM
- endometrial luminal cells: 5,738 nCPM
- endometrial glandular cells: 5,636 nCPM
- cdc: 5,324 nCPM
Immune cell
- non-classical monocyte: 2,462 nTPM
- intermediate monocyte: 1,846 nTPM
- neutrophil: 1,585 nTPM
- total PBMC: 746 nTPM
- classical monocyte: 654 nTPM
- basophil: 402 nTPM
Brain region
- cerebral cortex: 136 nTPM
- choroid plexus: 95 nTPM
- hypothalamus: 86 nTPM
- white matter: 83 nTPM
- thalamus: 73 nTPM
- medulla oblongata: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.71
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- polyamine biosynthetic process
- putrescine catabolic process
- regulation of cell population proliferation
- spermidine acetylation
Molecular functions
- diamine N-acetyltransferase activity
- identical protein binding
- N-acetyltransferase activity
- spermidine binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SAT1 as an antibody target. Whether an autoantibody or antibody against SAT1 could matter depends on whether native SAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...